speb/financial-data huggingface dataset:
Financial ratios for CESC.NS — quarterly report dated 2025-12-31
Total revenue: 446140135.9028629
Gross profit: 186922134.34332183
Operating income: 109056477.66514426
Net income: 33864319.9287067
Capital expenditures: 0
Depreciation & amortization: 34309903.08566336
Owner earnings: 68174223.01437005
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.8665478444914783
P/E ratio: 15.548163235081171
Shares outstanding: 1325570430
Market cap (USD): 2474240628.838142
Effective tax rate (%): 21.038961038961038
Interest coverage ratio: 2.5428571428571427
COGS to revenue (%): 58.102372034956296
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -26.7067742901602
Rule of 40 score: -26.7067742901602
Financial ratios for CPHC — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 2844647
Buffett classification: The Gruesome
Stock price: 16.16
Shares outstanding: 5150334
Market cap (USD): 83229397.44
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPHC — annual report dated 2022-12-31
Total revenue: 66823881
Gross profit: 52939772
Operating income: 11037894
Net income: 7512946
Capital expenditures: 3837841
Operating cash flow: 11217442
Depreciation & amortization: 2981168
Net tangible assets: 71185043
Owner earnings: 6656273
Return on net tangible assets (%): 9.350662329444685
Capex to operating income (%): 34.769685231621175
Buffett classification: The Good
Stock price: 29.7
P/E ratio: 20.360178257636882
Shares outstanding: 5150334
Book value: 71185043
P/B ratio: 2.1488351113309014
Market cap (USD): 152964919.79999998
Debt to equity: 0.00026653070926711386
Current ratio: 2.943052274532609
Quick ratio: 2.917928314657626
Effective tax rate (%): 26.59372299029209
COGS to revenue (%): 20.77716647436266
SG&A to revenue (%): 48.22535075447055
Free cash flow (dilution-adjusted): 5151335
Buyback yield (%): 0
Retained earnings: 45221509
Inventory turnover: 52.978021390986484
Receivables turnover: 7.616155409783376
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.486341941969538
FCF margin (%): 7.708823436938659
Rule of 40 score: 7.708823436938659
Financial ratios for CPHC — annual report dated 2023-12-31
Total revenue: 61436858
Gross profit: 48804321
Operating income: 5168043
Net income: 10563249
Capital expenditures: 428396
Operating cash flow: 11536509
Depreciation & amortization: 3145372
Net tangible assets: 81796597
Owner earnings: 13280225
Return on net tangible assets (%): 16.235669315191682
Capex to operating income (%): 8.289327314033573
Buffett classification: The Great
Stock price: 19.66
P/E ratio: 9.585646086729565
Shares outstanding: 5150334
Book value: 81796597
P/B ratio: 1.2378946087451537
Market cap (USD): 101255566.44
Debt to equity: 0.0007628679222437579
Current ratio: 3.2758266851007103
Quick ratio: 3.253325229187845
Effective tax rate (%): 29.48549119577385
COGS to revenue (%): 20.561821374393855
SG&A to revenue (%): 54.59445207956436
Free cash flow (dilution-adjusted): 2249786
Buyback yield (%): 0
Retained earnings: 54395462
Inventory turnover: 50.65780567028913
Receivables turnover: 13.451001607897263
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.5216332650165105
FCF margin (%): 3.661948337266857
Revenue growth (%): -8.061523693902185
Rule of 40 score: -4.399575356635328
Financial ratios for CPHC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.75
Shares outstanding: 5150334
Market cap (USD): 96568762.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPHC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.99
Shares outstanding: 5150334
Market cap (USD): 102955176.66
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPHC — annual report dated 2024-12-31
Total revenue: 61562288
Gross profit: 48519665
Operating income: 4749848
Net income: 2112842
Capital expenditures: 11984131
Operating cash flow: 6487814
Depreciation & amortization: 3620899
Net tangible assets: 84088674
Owner earnings: -6250390
Return on net tangible assets (%): -7.433093783831102
Capex to operating income (%): 252.3055685150346
Buffett classification: The Gruesome
Stock price: 19.99
P/E ratio: 48.728289507686796
Shares outstanding: 5150334
Book value: 84088674
P/B ratio: 1.2243643734945802
Market cap (USD): 102955176.66
Debt to equity: 0.00211450593215443
Current ratio: 2.2871743593241276
Quick ratio: 2.2636907179946877
Effective tax rate (%): 30.42370947404887
COGS to revenue (%): 21.18605955646093
SG&A to revenue (%): 53.85227884967498
Free cash flow (dilution-adjusted): -6943747
Buyback yield (%): 0
Retained earnings: 55097420
Inventory turnover: 52.03353972344789
Receivables turnover: 16.97995524033908
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.785786673593886
FCF margin (%): -11.27922178590893
Revenue growth (%): 0.20416083127167733
Rule of 40 score: -11.075060954637253
Financial ratios for CPHC — quarterly report dated 2025-03-31
Total revenue: 13141632
Gross profit: 10915834
Operating income: 649671
Net income: -299210
Capital expenditures: 858600
Operating cash flow: 3374172
Depreciation & amortization: 931488
Net tangible assets: 83748340
Owner earnings: -226322
Return on net tangible assets (%): -0.27024058029090486
Capex to operating income (%): 132.15920057998588
Buffett classification: The Gruesome
Stock price: 17.86
Shares outstanding: 5150334
Book value: 83748340
P/B ratio: 1.0983497134390963
Market cap (USD): 91984965.24
Debt to equity: 0.002027837208474819
Current ratio: 2.131607369077968
Quick ratio: 2.111432913630342
COGS to revenue (%): 16.93699838802365
SG&A to revenue (%): 58.58210761037898
Free cash flow (dilution-adjusted): 2133115
Buyback yield (%): 0
Retained earnings: 54438359
Inventory turnover: 8.853294830336225
Receivables turnover: 3.203034754460842
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6503428236471122
FCF margin (%): 16.23173590616447
Rule of 40 score: 16.23173590616447
Financial ratios for CPHC — quarterly report dated 2025-06-30
Total revenue: 15665734
Gross profit: 12322524
Operating income: 431818
Net income: -327406
Capital expenditures: 1173371
Operating cash flow: 4381724
Depreciation & amortization: 986418
Net tangible assets: 83600611
Owner earnings: -514359
Return on net tangible assets (%): -0.6152574650441252
Capex to operating income (%): 271.7281354644781
Buffett classification: The Gruesome
Stock price: 18.52
Shares outstanding: 5150334
Book value: 83600611
P/B ratio: 1.1409508200843173
Market cap (USD): 95384185.67999999
Debt to equity: 0.0018030490231704167
Current ratio: 1.9448074541207847
Quick ratio: 1.919474428514108
COGS to revenue (%): 21.340908763036573
SG&A to revenue (%): 58.18398295285749
Free cash flow (dilution-adjusted): 2782055
Buyback yield (%): 0
Retained earnings: 53751961
Inventory turnover: 9.196289806595717
Receivables turnover: 5.229652962936133
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.42932871774819853
FCF margin (%): 17.75885509099031
Revenue growth (%): 19.206914331492467
Rule of 40 score: 36.96576942248278
Financial ratios for CPHC — quarterly report dated 2025-09-30
Total revenue: 18314701
Gross profit: 14285156
Operating income: 1051046
Net income: 487283
Capital expenditures: 1643031
Operating cash flow: 1247756
Depreciation & amortization: 1026994
Net tangible assets: 84124866
Owner earnings: -128754
Return on net tangible assets (%): -0.15305106102635574
Capex to operating income (%): 156.3234149599542
Buffett classification: The Gruesome
Stock price: 16.17
P/E ratio: 42.727173316122254
Shares outstanding: 5150334
Book value: 84124866
P/B ratio: 0.989967708002055
Market cap (USD): 83280900.78000002
Debt to equity: 0.0014939934644294115
Current ratio: 2.069778335863953
Quick ratio: 2.047049979306302
Effective tax rate (%): 24.25060199010389
COGS to revenue (%): 22.00169688819927
SG&A to revenue (%): 54.69997571895932
Free cash flow (dilution-adjusted): -788269
Buyback yield (%): 0
Retained earnings: 53883222
Inventory turnover: 13.8602842539023
Receivables turnover: 5.661425756677438
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.034601077942174
FCF margin (%): -4.304023308925436
Revenue growth (%): 16.909306643404005
Rule of 40 score: 12.605283334478568
Financial ratios for CPHC — annual report dated 2025-12-31
Total revenue: 59567585
Gross profit: 47532466
Operating income: 2517866
Net income: -529431
Capital expenditures: 4182822
Operating cash flow: 8900209
Depreciation & amortization: 3998041
Net tangible assets: 83878048
Owner earnings: -714212
Return on net tangible assets (%): -0.8514885801825048
Capex to operating income (%): 166.1256794444184
Buffett classification: The Gruesome
Stock price: 15.26
Shares outstanding: 5150334
Book value: 83878048
P/B ratio: 0.9370043618563942
Market cap (USD): 78594096.84
Debt to equity: 0.001397040140943671
Current ratio: 2.6007499650284256
Quick ratio: 2.5727707321723634
COGS to revenue (%): 20.20414122882437
SG&A to revenue (%): 57.13453886035501
Free cash flow (dilution-adjusted): 3115831
Buyback yield (%): 0
Retained earnings: 53136175
Inventory turnover: 44.670639412959
Receivables turnover: 21.506693990698707
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.4456738413909314
FCF margin (%): 5.230749240547523
Revenue growth (%): -3.2401378584239757
Rule of 40 score: 1.990611382123547
Financial ratios for CPHC — quarterly report dated 2025-12-31
Total revenue: 12445518
Gross profit: 10008952
Operating income: 385332
Net income: -390098
Capital expenditures: 507820
Operating cash flow: -103443
Depreciation & amortization: 1053141
Net tangible assets: 83878048
Owner earnings: 155223
Capex to operating income (%): 131.7876532444749
Buffett classification: The Gruesome
Stock price: 15.26
Shares outstanding: 5150334
Book value: 83878048
P/B ratio: 0.9370043618563942
Market cap (USD): 78594096.84
Debt to equity: 0.001397040140943671
Current ratio: 2.6007499650284256
Quick ratio: 2.5727707321723634
COGS to revenue (%): 19.577859274318673
SG&A to revenue (%): 57.86769984182257
Free cash flow (dilution-adjusted): -1011070
Buyback yield (%): 0
Retained earnings: 53136175
Inventory turnover: 9.043779391950828
Receivables turnover: 4.493416128616472
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.3742837754871985
FCF margin (%): -8.123968805476798
Revenue growth (%): -32.04629439486891
Rule of 40 score: -40.17026320034571
Financial ratios for CTSO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.19
Shares outstanding: 62842748
Market cap (USD): 263311114.12000003
Buyback yield (%): 0.03418009919588273
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTSO — annual report dated 2022-12-31
Total revenue: 29359910
Gross profit: 15404158
Operating income: -31521879
Net income: -32812583
Capital expenditures: 6087365
Operating cash flow: -28234282
Depreciation & amortization: 1131629
Net tangible assets: 30984440
Owner earnings: -37768319
Return on net tangible assets (%): -121.89447025668368
Buffett classification: The Gruesome
Stock price: 1.55
Shares outstanding: 62842748
Book value: 35374973
P/B ratio: 2.753535936267711
Market cap (USD): 97406259.4
Debt to equity: 0.515928139365647
Current ratio: 3.4751670483620862
Quick ratio: 3.1188370807011996
COGS to revenue (%): 47.53336096738716
R&D to revenue (%): 51.49507270287954
SG&A to revenue (%): 126.48550012585189
Free cash flow (dilution-adjusted): -38489949
Buyback yield (%): 0.04143265561022046
Retained earnings: -253997878
Inventory turnover: 4.031606321495407
Receivables turnover: 5.1827388846591695
Capitalized R&D asset: 15118907
ROCI (R&D-adjusted, %): -31.24110320230688
FCF margin (%): -131.09695840348286
Rule of 40 score: -131.09695840348286
Financial ratios for CTSO — annual report dated 2023-12-31
Total revenue: 31084953
Gross profit: 21953237
Operating income: -31948620
Net income: -29246760
Capital expenditures: 538115
Operating cash flow: -21655136
Depreciation & amortization: 2023422
Net tangible assets: 19574662
Owner earnings: -27761453
Return on net tangible assets (%): -141.82340926244345
Buffett classification: The Gruesome
Stock price: 1.11
Shares outstanding: 62842748
Book value: 23481214
P/B ratio: 2.9706918168711383
Market cap (USD): 69755450.28
Debt to equity: 0.7799065244241631
Current ratio: 1.8095788905804615
Quick ratio: 1.5690605711536785
Interest coverage ratio: -202.3460488564896
COGS to revenue (%): 29.37664406312598
R&D to revenue (%): 50.16717252234546
SG&A to revenue (%): 123.23459199053639
Free cash flow (dilution-adjusted): -26746714
Buyback yield (%): 0
Retained earnings: -283289661
Inventory turnover: 2.7050388098643974
Receivables turnover: 5.132009822567736
Capitalized R&D asset: 25724109.69
ROCI (R&D-adjusted, %): -41.135473655004745
Rosenberg metric: 0.43317145875690616
FCF margin (%): -86.04392614008457
Revenue growth (%): 5.875505067965127
Rule of 40 score: -80.16842107211944
Financial ratios for CTSO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.5
Shares outstanding: 62842748
Market cap (USD): 94264122
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTSO — quarterly report dated 2024-12-31
Capital expenditures: 124193
Buffett classification: The Gruesome
Stock price: 0.91
Shares outstanding: 62842748
Market cap (USD): 57186900.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTSO — annual report dated 2024-12-31
Total revenue: 35595000
Gross profit: 24887000
Operating income: -16452000
Net income: -20719000
Capital expenditures: 284000
Operating cash flow: -14428000
Depreciation & amortization: 1744000
Net tangible assets: 7386000
Owner earnings: -19259000
Return on net tangible assets (%): -260.75006769564044
Buffett classification: The Gruesome
Stock price: 0.91
Shares outstanding: 62842748
Book value: 11107000
P/B ratio: 5.148726089853246
Market cap (USD): 57186900.68
Debt to equity: 2.4212658683712975
Current ratio: 2.198880407124682
Quick ratio: 1.9207124681933843
Interest coverage ratio: -11.759828448892065
COGS to revenue (%): 30.082876808540526
R&D to revenue (%): 21.370979070094116
SG&A to revenue (%): 94.7661188369153
Free cash flow (dilution-adjusted): -18857000
Buyback yield (%): 0
Retained earnings: -304009000
Inventory turnover: 3.9180387852177097
Receivables turnover: 4.862704918032787
Capitalized R&D asset: 23044515.450000003
ROCI (R&D-adjusted, %): -35.679004735417394
Rosenberg metric: 0.1881287576689182
FCF margin (%): -52.97654164910802
Revenue growth (%): 14.508778572063468
Rule of 40 score: -38.46776307704455
Financial ratios for CTSO — quarterly report dated 2025-03-31
Total revenue: 8727000
Gross profit: 6207000
Operating income: -3888000
Net income: -1479000
Capital expenditures: 2000
Operating cash flow: -3466000
Depreciation & amortization: 405000
Net tangible assets: 10838078
Owner earnings: -1076000
Return on net tangible assets (%): -9.927959551499814
Buffett classification: The Gruesome
Stock price: 1
Shares outstanding: 62842748
Book value: 14542784
P/B ratio: 4.321232303250877
Market cap (USD): 62842748
Debt to equity: 1.8549902824658608
Current ratio: 2.610181976991528
Quick ratio: 2.3001466916925173
Interest coverage ratio: -6.426446280991735
COGS to revenue (%): 28.875902371949124
R&D to revenue (%): 19.055803827202933
SG&A to revenue (%): 96.61968603185517
Free cash flow (dilution-adjusted): -4331000
Buyback yield (%): 0
Retained earnings: -305486976
Inventory turnover: 0.8348451097291258
Receivables turnover: 1.1377504612211178
Capitalized R&D asset: 1663000
ROCI (R&D-adjusted, %): -6.50766394111215
FCF margin (%): -49.62759252893319
Rule of 40 score: -49.62759252893319
Financial ratios for CTSO — quarterly report dated 2025-06-30
Total revenue: 9617000
Gross profit: 6814000
Operating income: -3615000
Net income: 1947000
Capital expenditures: 37000
Operating cash flow: -1509000
Depreciation & amortization: 503000
Net tangible assets: 7847000
Owner earnings: 2413000
Return on net tangible assets (%): 30.750605326876514
Buffett classification: The Gruesome
Stock price: 1.28
P/E ratio: 171.87760136752138
Shares outstanding: 62842748
Book value: 11586000
P/B ratio: 6.942751375798378
Market cap (USD): 80438717.44
Debt to equity: 2.33531848783014
Current ratio: 2.335602519813046
Quick ratio: 1.9586466165413534
Interest coverage ratio: -5.8685064935064934
COGS to revenue (%): 29.146303421025266
R&D to revenue (%): 13.12259540397213
SG&A to revenue (%): 95.32078610793387
Free cash flow (dilution-adjusted): -2214000
Buyback yield (%): 0
Retained earnings: -303540000
Inventory turnover: 0.7555256064690027
Receivables turnover: 1.2420250548882863
Capitalized R&D asset: 2376210
ROCI (R&D-adjusted, %): -8.212374775473723
Rosenberg metric: 0.36500300661455204
FCF margin (%): -23.021732348965372
Revenue growth (%): 10.198235361521714
Rule of 40 score: -12.823496987443658
Financial ratios for CTSO — quarterly report dated 2025-09-30
Total revenue: 9485000
Gross profit: 6666000
Operating income: -2862000
Net income: -3170000
Capital expenditures: 17000
Operating cash flow: -2577000
Depreciation & amortization: 401000
Net tangible assets: 5428000
Owner earnings: -2786000
Return on net tangible assets (%): -51.326455416359615
Buffett classification: The Gruesome
Stock price: 0.93
Shares outstanding: 62842748
Book value: 9020000
P/B ratio: 6.479352066518847
Market cap (USD): 58443755.64
Debt to equity: 3.0084257206208425
Current ratio: 2.107693829113924
Quick ratio: 1.7119264240506329
Interest coverage ratio: -4.437209302325582
COGS to revenue (%): 29.720611491829203
R&D to revenue (%): 9.678439641539272
SG&A to revenue (%): 90.7749077490775
Free cash flow (dilution-adjusted): -3010000
Buyback yield (%): 0
Retained earnings: -306710000
Inventory turnover: 0.7043978010994503
Receivables turnover: 1.2770970782280866
Capitalized R&D asset: 2312330
ROCI (R&D-adjusted, %): -8.497949820199192
Rosenberg metric: -0.11727416798732171
FCF margin (%): -31.73431734317343
Revenue growth (%): -1.3725694083393989
Rule of 40 score: -33.10688675151283
Financial ratios for CTSO — quarterly report dated 2025-12-31
Total revenue: 9234000
Gross profit: 6804000
Operating income: -3875000
Net income: -5497000
Capital expenditures: 32000
Operating cash flow: -4825000
Depreciation & amortization: 385000
Net tangible assets: 2677000
Owner earnings: -5144000
Return on net tangible assets (%): -192.1553978333956
Buffett classification: The Gruesome
Stock price: 0.64
Shares outstanding: 62842748
Book value: 5903000
P/B ratio: 6.813376032525834
Market cap (USD): 40219358.72
Debt to equity: 4.931560223615111
Current ratio: 2.1252446183953033
Quick ratio: 1.5813163044597796
Interest coverage ratio: -5.194369973190349
COGS to revenue (%): 26.31578947368421
R&D to revenue (%): 13.461121940654106
SG&A to revenue (%): 102.1875676846437
Free cash flow (dilution-adjusted): -6078000
Buyback yield (%): 0
Retained earnings: -312207000
Inventory turnover: 0.4601401249763302
Receivables turnover: 1.223046357615894
Capitalized R&D asset: 2274520
ROCI (R&D-adjusted, %): -10.26735953882058
Rosenberg metric: 0.1503267973856209
FCF margin (%): -65.82196231319038
Revenue growth (%): -2.6462836056931995
Rule of 40 score: -68.46824591888358
Financial ratios for CTSO — annual report dated 2025-12-31
Total revenue: 37063000
Gross profit: 26491000
Operating income: -14239000
Net income: -8198000
Capital expenditures: 88000
Operating cash flow: -12377000
Depreciation & amortization: 1631000
Net tangible assets: 2677000
Owner earnings: -6655000
Return on net tangible assets (%): -248.5991781845349
Buffett classification: The Gruesome
Stock price: 0.64
Shares outstanding: 62842748
Book value: 5903000
P/B ratio: 6.813376032525834
Market cap (USD): 40219358.72
Debt to equity: 4.931560223615111
Current ratio: 2.1252446183953033
Quick ratio: 1.5813163044597796
Interest coverage ratio: -5.451378254211332
COGS to revenue (%): 28.524404392520843
R&D to revenue (%): 13.719882362463911
SG&A to revenue (%): 96.17408196854005
Free cash flow (dilution-adjusted): -15633000
Buyback yield (%): 0
Retained earnings: -312207000
Inventory turnover: 2.0018935807612195
Receivables turnover: 4.909006622516556
Capitalized R&D asset: 15327855.86
ROCI (R&D-adjusted, %): -37.314246269662405
Rosenberg metric: 0.21085841987642961
FCF margin (%): -42.179532147964274
Revenue growth (%): 4.12417474364377
Rule of 40 score: -38.0553574043205
Financial ratios for DECB.BR — annual report dated 2021-12-31
Capital expenditures: 1092045.4545454546
Buffett classification: The Gruesome
Stock price: 3.227272727272727
Shares outstanding: 139295712
Market cap (USD): 449545252.3636363
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DECB.BR — annual report dated 2022-12-31
Total revenue: 1036280851.0638299
Gross profit: 277577659.5744681
Operating income: 58938297.872340426
Net income: 8086170.212765958
Capital expenditures: 653191.4893617021
Operating cash flow: 85273404.25531915
Depreciation & amortization: 53287234.042553194
Net tangible assets: 310670212.7659575
Owner earnings: 60720212.765957445
Return on net tangible assets (%): 19.544909769544223
Capex to operating income (%): 1.1082632395942384
Buffett classification: The Great
Stock price: 2.2553191489361706
P/E ratio: 38.8510603131167
Shares outstanding: 139295712
Book value: 340022340.425532
P/B ratio: 0.9239283696628194
Market cap (USD): 314156286.6382979
Debt to equity: 0.4605454585274434
Current ratio: 1.670745576719393
Quick ratio: 0.9253338079280469
Effective tax rate (%): 53.44194022537971
Interest coverage ratio: 7.763733183856502
COGS to revenue (%): 73.2140510664159
R&D to revenue (%): 0.6682038057538003
SG&A to revenue (%): 20.638248072074436
Free cash flow (dilution-adjusted): 32904255.31914894
Buyback yield (%): 0
Retained earnings: 271991489.36170214
Inventory turnover: 4.153113753625045
Receivables turnover: 11.075908491381272
Capitalized R&D asset: 6924468.085106383
ROCI (R&D-adjusted, %): 12.29916175143511
FCF margin (%): 3.175225643257804
Rule of 40 score: 3.175225643257804
Financial ratios for DECB.BR — annual report dated 2023-12-31
Total revenue: 962331111.111111
Gross profit: 312303333.3333333
Operating income: 59232222.222222224
Net income: 15134444.444444444
Capital expenditures: 1911111.111111111
Operating cash flow: 148636666.66666666
Depreciation & amortization: 49795555.55555555
Net tangible assets: 319263333.3333333
Owner earnings: 63018888.88888889
Return on net tangible assets (%): 19.738843239819445
Capex to operating income (%): 3.226472077885535
Buffett classification: The Great
Stock price: 2.255555555555555
P/E ratio: 20.759877788708607
Shares outstanding: 139295712
Book value: 350014444.4444444
P/B ratio: 0.8976464316075844
Market cap (USD): 314189217.0666666
Debt to equity: 0.371762435201087
Current ratio: 1.3915420381864245
Quick ratio: 0.7969340748674144
Effective tax rate (%): 21.30362236934173
Interest coverage ratio: 5.9146787972928
COGS to revenue (%): 67.54720597438167
R&D to revenue (%): 0.8306219388568037
SG&A to revenue (%): 23.742694244762138
Free cash flow (dilution-adjusted): 85012222.22222222
Buyback yield (%): 0.23941694410938713
Retained earnings: 285811111.1111111
Inventory turnover: 4.231921065385812
Receivables turnover: 10.545580732749697
Capitalized R&D asset: 12632726.95035461
ROCI (R&D-adjusted, %): 12.185768427867915
Rosenberg metric: 5.014922927228963
FCF margin (%): 8.83398876339629
Revenue growth (%): -7.136071256822241
Rule of 40 score: 1.6979175065740488
Financial ratios for DECB.BR — annual report dated 2024-12-31
Total revenue: 861450000
Gross profit: 276382291.6666667
Operating income: 66166666.66666667
Net income: 16534375
Capital expenditures: 40055208.333333336
Operating cash flow: 75127083.33333334
Depreciation & amortization: 49127083.333333336
Net tangible assets: 336168750
Owner earnings: 25606250
Return on net tangible assets (%): 7.617082194582333
Capex to operating income (%): 60.53683879093199
Buffett classification: The Good
Stock price: 2.3333333333333335
P/E ratio: 19.657430534870535
Shares outstanding: 139295712
Book value: 370410416.66666675
P/B ratio: 0.8774681093606752
Market cap (USD): 325023328
Debt to equity: 0.3354387306872444
Current ratio: 1.4711319066597603
Quick ratio: 0.9715749774183744
Effective tax rate (%): 49.27443137025898
Interest coverage ratio: 4.972211350293542
COGS to revenue (%): 67.91661829860507
R&D to revenue (%): 0.8468038384893687
SG&A to revenue (%): 23.390189989745974
Free cash flow (dilution-adjusted): 33972916.666666664
Buyback yield (%): 1.248307834281565
Retained earnings: 275196875
Inventory turnover: 4.81310253224217
Receivables turnover: 7.435841642914302
Capitalized R&D asset: 14935399.468085106
ROCI (R&D-adjusted, %): 12.609355820935953
Rosenberg metric: -4.49387510425354
FCF margin (%): 3.9436899026834595
Revenue growth (%): -10.482993841343582
Rule of 40 score: -6.539303938660122
Financial ratios for DECB.BR — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 336168750
Buffett classification: The Gruesome
Stock price: 2.3333333333333335
Shares outstanding: 139295712
Book value: 370410416.66666675
P/B ratio: 0.8774681093606752
Market cap (USD): 325023328
Debt to equity: 0.3354387306872444
Current ratio: 1.4711319066597603
Quick ratio: 0.9715749774183744
Buyback yield (%): 0
Retained earnings: 275196875
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DECB.BR — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.3294117647058825
Shares outstanding: 139295712
Market cap (USD): 324477070.3058824
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DTM — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 166000000
Buffett classification: The Gruesome
Stock price: 39.86
Shares outstanding: 102014118
Market cap (USD): 4066282743.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DTM — annual report dated 2022-12-31
Total revenue: 920000000
Gross profit: 750000000
Operating income: 455000000
Net income: 382000000
Capital expenditures: 338000000
Operating cash flow: 725000000
Depreciation & amortization: 189000000
Net tangible assets: 1509000000
Owner earnings: 233000000
Return on net tangible assets (%): 15.440689198144467
Capex to operating income (%): 74.28571428571429
Buffett classification: The Good
Stock price: 48.12
P/E ratio: 12.850574236020941
Shares outstanding: 102014118
Book value: 4154000000
P/B ratio: 1.1817331146268657
Market cap (USD): 4908919358.16
Debt to equity: 0.824265767934521
Current ratio: 0.42671009771986973
Quick ratio: 0.42671009771986973
Effective tax rate (%): 20.74688796680498
Interest coverage ratio: 3.321167883211679
COGS to revenue (%): 18.478260869565215
Free cash flow (dilution-adjusted): 370000000
Buyback yield (%): 0.06111324674774213
Retained earnings: 547000000
Receivables turnover: 5.714285714285714
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.535953278987711
FCF margin (%): 40.21739130434783
Rule of 40 score: 40.21739130434783
Financial ratios for DTM — annual report dated 2023-12-31
Total revenue: 922000000
Gross profit: 740000000
Operating income: 467000000
Net income: 396000000
Capital expenditures: 772000000
Operating cash flow: 798000000
Depreciation & amortization: 200000000
Net tangible assets: 1698000000
Owner earnings: -176000000
Return on net tangible assets (%): -10.365135453474677
Capex to operating income (%): 165.31049250535332
Buffett classification: The Gruesome
Stock price: 50.39
P/E ratio: 12.981038904090909
Shares outstanding: 102014118
Book value: 4280000000
P/B ratio: 1.2010493939299065
Market cap (USD): 5140491406.02
Debt to equity: 0.764018691588785
Current ratio: 0.6267281105990783
Quick ratio: 0.6267281105990783
Effective tax rate (%): 20.8
Interest coverage ratio: 3.1133333333333333
COGS to revenue (%): 19.739696312364423
Free cash flow (dilution-adjusted): 6000000
Buyback yield (%): 0
Retained earnings: 661000000
Receivables turnover: 5.455621301775148
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.46326626111371
FCF margin (%): 0.6507592190889371
Revenue growth (%): 0.21739130434782608
Rule of 40 score: 0.8681505234367631
Financial ratios for DTM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 74.77
Shares outstanding: 102014118
Market cap (USD): 7627595602.86
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DTM — annual report dated 2024-12-31
Total revenue: 981000000
Gross profit: 772000000
Operating income: 489000000
Net income: 367000000
Capital expenditures: 350000000
Operating cash flow: 763000000
Depreciation & amortization: 227000000
Net tangible assets: 1930000000
Owner earnings: 244000000
Return on net tangible assets (%): 12.642487046632125
Capex to operating income (%): 71.57464212678937
Buffett classification: The Good
Stock price: 95.2
P/E ratio: 26.462517802724797
Shares outstanding: 102014118
Book value: 4766000000
P/B ratio: 2.0377138131766683
Market cap (USD): 9711744033.6
Debt to equity: 0.738774653797734
Current ratio: 0.7276995305164319
Quick ratio: 0.7276995305164319
Effective tax rate (%): 27.18253968253968
Interest coverage ratio: 3.196078431372549
COGS to revenue (%): 21.30479102956167
Free cash flow (dilution-adjusted): 390000000
Buyback yield (%): 0
Retained earnings: 723000000
Receivables turnover: 5.45
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.142496582185299
FCF margin (%): 39.75535168195719
Revenue growth (%): 6.399132321041215
Rule of 40 score: 46.1544840029984
Financial ratios for DTM — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 95.2
Shares outstanding: 102014118
Market cap (USD): 9711744033.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DTM — quarterly report dated 2025-03-31
Total revenue: 303000000
Gross profit: 240000000
Operating income: 148000000
Net income: 111000000
Capital expenditures: 71000000
Operating cash flow: 247000000
Depreciation & amortization: 67000000
Net tangible assets: 1959000000
Owner earnings: 107000000
Return on net tangible assets (%): 5.461970393057682
Capex to operating income (%): 47.97297297297297
Buffett classification: The Good
Stock price: 93.18
P/E ratio: 21.40917908837838
Shares outstanding: 102014118
Book value: 4782000000
P/B ratio: 1.9878033281555836
Market cap (USD): 9505675515.24
Debt to equity: 0.7179004600585529
Current ratio: 0.8188976377952756
Quick ratio: 0.8188976377952756
Effective tax rate (%): 23.972602739726025
Interest coverage ratio: 3.7
COGS to revenue (%): 20.792079207920793
Free cash flow (dilution-adjusted): 170000000
Buyback yield (%): 0
Retained earnings: 747000000
Receivables turnover: 1.8035714285714286
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5495759606323944
FCF margin (%): 56.10561056105611
Rule of 40 score: 56.10561056105611
Financial ratios for DTM — quarterly report dated 2025-06-30
Total revenue: 309000000
Gross profit: 246000000
Operating income: 155000000
Net income: 111000000
Capital expenditures: 81000000
Operating cash flow: 185000000
Depreciation & amortization: 68000000
Net tangible assets: 2000000000
Owner earnings: 98000000
Return on net tangible assets (%): 4.9
Capex to operating income (%): 52.25806451612903
Buffett classification: The Good
Stock price: 106.97
P/E ratio: 49.15518109216217
Shares outstanding: 102014118
Book value: 4815000000
P/B ratio: 2.2663447980186917
Market cap (USD): 10912450202.46
Debt to equity: 0.7059190031152648
Current ratio: 0.879154078549849
Quick ratio: 0.879154078549849
Effective tax rate (%): 23.448275862068964
Interest coverage ratio: 3.875
COGS to revenue (%): 20.388349514563107
Free cash flow (dilution-adjusted): 98000000
Buyback yield (%): 0
Retained earnings: 770000000
Receivables turnover: 1.8841463414634145
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6097206355800187
FCF margin (%): 31.715210355987054
Revenue growth (%): 1.9801980198019802
Rule of 40 score: 33.695408375789036
Financial ratios for DTM — quarterly report dated 2025-09-30
Total revenue: 314000000
Gross profit: 249000000
Operating income: 155000000
Net income: 118000000
Capital expenditures: 143000000
Operating cash flow: 274000000
Depreciation & amortization: 69000000
Net tangible assets: 2044000000
Owner earnings: 44000000
Return on net tangible assets (%): 2.152641878669276
Capex to operating income (%): 92.25806451612904
Buffett classification: The Gruesome
Stock price: 110.89
P/E ratio: 33.27160454417647
Shares outstanding: 102014118
Book value: 4844000000
P/B ratio: 2.3353314502518576
Market cap (USD): 11312345545.02
Debt to equity: 0.6967382328654005
Current ratio: 0.9226361031518625
Quick ratio: 0.9226361031518625
Effective tax rate (%): 22.875816993464053
Interest coverage ratio: 3.875
COGS to revenue (%): 20.70063694267516
Free cash flow (dilution-adjusted): 124000000
Buyback yield (%): 0
Retained earnings: 801000000
Receivables turnover: 1.7942857142857143
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5959637561779243
FCF margin (%): 39.490445859872615
Revenue growth (%): 1.6181229773462782
Rule of 40 score: 41.1085688372189
Financial ratios for DTM — annual report dated 2025-12-31
Total revenue: 1243000000
Gross profit: 985000000
Operating income: 614000000
Net income: 454000000
Capital expenditures: 426000000
Operating cash flow: 867000000
Depreciation & amortization: 275000000
Net tangible assets: 2093000000
Owner earnings: 303000000
Return on net tangible assets (%): 14.476827520305783
Capex to operating income (%): 69.38110749185668
Buffett classification: The Good
Stock price: 118.18
P/E ratio: 26.555128778061675
Shares outstanding: 102014118
Book value: 4878000000
P/B ratio: 2.4715105504797052
Market cap (USD): 12056028465.24
Debt to equity: 0.6912669126691267
Current ratio: 1.0743243243243243
Quick ratio: 1.0743243243243243
Effective tax rate (%): 24.08026755852843
Interest coverage ratio: 3.813664596273292
COGS to revenue (%): 20.75623491552695
Free cash flow (dilution-adjusted): 415000000
Buyback yield (%): 0
Retained earnings: 827000000
Receivables turnover: 6.611702127659575
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.275551921504498
FCF margin (%): 33.3869670152856
Revenue growth (%): 26.70744138634047
Rule of 40 score: 60.09440840162607
Financial ratios for DTM — quarterly report dated 2025-12-31
Total revenue: 317000000
Gross profit: 250000000
Operating income: 156000000
Net income: 114000000
Capital expenditures: 131000000
Operating cash flow: 161000000
Depreciation & amortization: 71000000
Net tangible assets: 2093000000
Owner earnings: 54000000
Return on net tangible assets (%): 2.580028666985189
Capex to operating income (%): 83.97435897435898
Buffett classification: The Gruesome
Stock price: 118.18
P/E ratio: 26.555128778061675
Shares outstanding: 102014118
Book value: 4878000000
P/B ratio: 2.4715105504797052
Market cap (USD): 12056028465.24
Debt to equity: 0.6912669126691267
Current ratio: 1.0743243243243243
Quick ratio: 1.0743243243243243
Effective tax rate (%): 25.97402597402597
Interest coverage ratio: 3.8048780487804876
COGS to revenue (%): 21.13564668769716
Free cash flow (dilution-adjusted): 23000000
Buyback yield (%): 0
Retained earnings: 827000000
Receivables turnover: 1.6861702127659575
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5944399018806215
FCF margin (%): 7.255520504731862
Revenue growth (%): 0.9554140127388535
Rule of 40 score: 8.210934517470715
Financial ratios for EM2.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.744360902255639
Shares outstanding: 1538759590
Market cap (USD): 1145392476.7669172
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EM2.AX — annual report dated 2022-06-30
Operating income: -21451375.862068966
Net income: -20729817.931034483
Capital expenditures: 347917.2413793104
Depreciation & amortization: 401784.8275862069
Net tangible assets: 7250382.068965518
Owner earnings: -20675950.344827585
Return on net tangible assets (%): -285.1704937499607
Buffett classification: The Gruesome
Stock price: 0.14482758620689656
Shares outstanding: 1538759590
Book value: 7091182.068965517
P/B ratio: 31.427036424256492
Market cap (USD): 222854837.17241383
Debt to equity: 0.909696880457847
Current ratio: 6.2203718587638255
Quick ratio: 6.2203718587638255
Interest coverage ratio: -78.12216188792219
Free cash flow (dilution-adjusted): -20505608.275862068
Buyback yield (%): 0.49637847771732996
Retained earnings: -51451578.62068966
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -140.12562541733158
Rule of 40 score: 0
Financial ratios for EM2.AX — annual report dated 2023-06-30
Operating income: -8909388.079470199
Net income: -9047219.867549669
Capital expenditures: 1990377.4834437086
Depreciation & amortization: 400274.8344370861
Net tangible assets: 3009300.6622516555
Owner earnings: -10637322.516556293
Return on net tangible assets (%): -353.4815463934769
Buffett classification: The Gruesome
Stock price: 0.06622516556291391
Shares outstanding: 1538759590
Book value: -5509231.78807947
Market cap (USD): 101904608.60927153
Debt to equity: -3.139504432055045
Current ratio: 2.748432377700488
Quick ratio: 2.748432377700488
Interest coverage ratio: -33.798043442215224
Free cash flow (dilution-adjusted): -11000415.23178808
Buyback yield (%): 0.14148408979209026
Retained earnings: -56597498.67549669
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -76.56438751397042
Rule of 40 score: 0
Financial ratios for EM2.AX — annual report dated 2024-06-30
Operating income: -4014282
Net income: -4296782.666666667
Capital expenditures: 39769.333333333336
Depreciation & amortization: 526348
Net tangible assets: 2131544.6666666665
Owner earnings: -3810204.0000000005
Return on net tangible assets (%): -178.7531858742815
Buffett classification: The Gruesome
Stock price: 0.03333333333333333
Shares outstanding: 1538759590
Book value: 2634765.333333332
P/B ratio: 19.467383179982132
Market cap (USD): 51291986.333333336
Debt to equity: 3.6123103183382828
Current ratio: 0.6338305729317489
Quick ratio: 0.6338305729317489
Interest coverage ratio: -8.580948241463831
Free cash flow (dilution-adjusted): -3478856.6666666665
Buyback yield (%): 0.2658050046661285
Retained earnings: -60343604
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -47.11636564833035
Rule of 40 score: 0
Financial ratios for ESCA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.01
Shares outstanding: 13805038
Market cap (USD): 179603544.38
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ESCA — annual report dated 2022-12-31
Total revenue: 343125000
Gross profit: 73639000
Operating income: 26315000
Net income: 17989000
Capital expenditures: 2071000
Operating cash flow: 8575000
Depreciation & amortization: 6063000
Net tangible assets: 85029000
Owner earnings: 21981000
Return on net tangible assets (%): 25.851180185583743
Capex to operating income (%): 7.8700361010830315
Buffett classification: The Great
Stock price: 8.82
P/E ratio: 6.768604989715938
Shares outstanding: 13805038
Book value: 158475000
P/B ratio: 0.768325825272125
Market cap (USD): 121760435.16000001
Debt to equity: 0.6595046537308724
Current ratio: 4.832901055442849
Quick ratio: 1.7032947279217276
Effective tax rate (%): 20.45193243123729
Interest coverage ratio: 6.961640211640212
COGS to revenue (%): 69.97974499089253
SG&A to revenue (%): 13.046265938069219
Free cash flow (dilution-adjusted): 6413000
Buyback yield (%): 0
Retained earnings: 156450000
Inventory turnover: 1.9702798063510298
Receivables turnover: 5.975809401069332
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.12984213383017
FCF margin (%): 1.8689981785063752
Rule of 40 score: 1.8689981785063752
Financial ratios for ESCA — annual report dated 2023-12-31
Total revenue: 292654000
Gross profit: 61771000
Operating income: 17811000
Net income: 9829000
Capital expenditures: 1945000
Operating cash flow: 48328000
Depreciation & amortization: 5671000
Net tangible assets: 93613000
Owner earnings: 13555000
Return on net tangible assets (%): 14.479826519820966
Capex to operating income (%): 10.92021784290607
Buffett classification: The Great
Stock price: 17.99
P/E ratio: 25.267334786855223
Shares outstanding: 13805038
Book value: 164579000
P/B ratio: 1.5090177581586959
Market cap (USD): 248352633.61999997
Debt to equity: 0.3635579265884469
Current ratio: 4.414111351611352
Quick ratio: 1.634469696969697
Effective tax rate (%): 21.323941407188023
Interest coverage ratio: 3.3297812675266405
COGS to revenue (%): 68.95343989830995
SG&A to revenue (%): 14.173734170727206
Free cash flow (dilution-adjusted): 45796000
Buyback yield (%): 0
Retained earnings: 160099000
Inventory turnover: 2.1824641474335404
Receivables turnover: 5.854836450935281
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.105451417805508
FCF margin (%): 15.648513261394001
Revenue growth (%): -14.709216757741347
Rule of 40 score: 0.9392965036526544
Financial ratios for ESCA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.99
Shares outstanding: 13805038
Market cap (USD): 179327443.62
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ESCA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.33
Shares outstanding: 13805038
Market cap (USD): 184021156.54
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ESCA — annual report dated 2024-12-31
Total revenue: 283956000
Gross profit: 62204000
Operating income: 16099000
Net income: 12986000
Capital expenditures: 3929000
Operating cash flow: 36049000
Depreciation & amortization: 6041000
Net tangible assets: 100833000
Owner earnings: 15098000
Return on net tangible assets (%): 14.973272638917814
Capex to operating income (%): 24.405242561649793
Buffett classification: The Great
Stock price: 13.33
P/E ratio: 14.170734370860927
Shares outstanding: 13805038
Book value: 168997000
P/B ratio: 1.088901912696675
Market cap (USD): 184021156.54
Debt to equity: 0.158736545619153
Current ratio: 3.879518770836353
Quick ratio: 1.675576170459487
Effective tax rate (%): 26.946444644464446
Interest coverage ratio: 6.993483927019983
COGS to revenue (%): 66.66737100114102
SG&A to revenue (%): 15.24989787150122
Free cash flow (dilution-adjusted): 34011000
Buyback yield (%): 1.192254217532373
Retained earnings: 164779000
Inventory turnover: 2.490049325879645
Receivables turnover: 5.822588582677166
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.392107800974797
FCF margin (%): 11.977559903647043
Revenue growth (%): -2.972110410245546
Rule of 40 score: 9.005449493401496
Financial ratios for ESCA — quarterly report dated 2025-03-31
Total revenue: 61508000
Gross profit: 14790000
Operating income: 3652000
Net income: 2619000
Capital expenditures: 543000
Operating cash flow: 3791000
Depreciation & amortization: 1239000
Net tangible assets: 101169000
Owner earnings: 3315000
Return on net tangible assets (%): 3.276695430418409
Capex to operating income (%): 14.86856516976999
Buffett classification: The Great
Stock price: 14.43
P/E ratio: 19.01553057846506
Shares outstanding: 13805038
Book value: 168765000
P/B ratio: 1.1803792157141588
Market cap (USD): 199206698.34
Debt to equity: 0.14767872485408703
Current ratio: 4.05204598837928
Quick ratio: 1.6722400791197922
Effective tax rate (%): 23.8441407385868
Interest coverage ratio: 14.967213114754099
COGS to revenue (%): 66.15237042335956
SG&A to revenue (%): 17.186382259218313
Free cash flow (dilution-adjusted): 2781000
Buyback yield (%): 0.6932497810103507
Retained earnings: 165337000
Inventory turnover: 0.5284217088089765
Receivables turnover: 1.2577037112769656
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9249623124848458
FCF margin (%): 4.521363074721988
Rule of 40 score: 4.521363074721988
Financial ratios for ESCA — quarterly report dated 2025-06-30
Total revenue: 61113000
Gross profit: 13437000
Operating income: 2621000
Net income: 1825000
Capital expenditures: 433000
Operating cash flow: 13292000
Depreciation & amortization: 1262000
Net tangible assets: 101309000
Owner earnings: 2654000
Return on net tangible assets (%): 2.619708021992123
Capex to operating income (%): 16.520412056466995
Buffett classification: The Great
Stock price: 13.31
P/E ratio: 41.346772227722774
Shares outstanding: 13805038
Book value: 168338000
P/B ratio: 1.0915245267259917
Market cap (USD): 183745055.78
Debt to equity: 0.13955850728890684
Current ratio: 4.145598962554709
Quick ratio: 1.7895607067596044
Effective tax rate (%): 25.782838552257015
Interest coverage ratio: 12.305164319248826
COGS to revenue (%): 66.91865887781651
SG&A to revenue (%): 16.770572545939487
Free cash flow (dilution-adjusted): 12246000
Buyback yield (%): 0.4299435414174495
Retained earnings: 165087000
Inventory turnover: 0.5627476882430648
Receivables turnover: 1.4576396508133378
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3979113998314614
FCF margin (%): 20.0382897255903
Revenue growth (%): -0.6421928854783118
Rule of 40 score: 19.396096840111987
Financial ratios for ESCA — quarterly report dated 2025-09-30
Total revenue: 75295000
Gross profit: 19066000
Operating income: 7301000
Net income: 5554000
Capital expenditures: 291000
Operating cash flow: -965000
Depreciation & amortization: 1266000
Net tangible assets: 104365000
Owner earnings: 6529000
Return on net tangible assets (%): 6.255928711732861
Capex to operating income (%): 3.985755375975894
Buffett classification: The Great
Stock price: 12.08
P/E ratio: 16.679821868373676
Shares outstanding: 13805038
Book value: 172327000
P/B ratio: 0.9677233343585161
Market cap (USD): 166764859.04
Debt to equity: 0.12545915613920047
Current ratio: 3.2970128354725787
Quick ratio: 1.414585764294049
Effective tax rate (%): 21.97246417533015
Interest coverage ratio: 35.78921568627451
COGS to revenue (%): 64.70549173251877
SG&A to revenue (%): 14.872169466764063
Free cash flow (dilution-adjusted): -1762000
Buyback yield (%): 0
Retained earnings: 168570000
Inventory turnover: 0.6040018844065359
Receivables turnover: 1.427231025854879
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.850535309319129
FCF margin (%): -2.340128826615313
Revenue growth (%): 23.206191808616826
Rule of 40 score: 20.866062982001512
Financial ratios for ESCA — quarterly report dated 2025-12-31
Total revenue: 68951000
Gross profit: 17352000
Operating income: 5153000
Net income: 3703000
Capital expenditures: 1245000
Operating cash flow: 14896000
Depreciation & amortization: 1296000
Net tangible assets: 105445000
Owner earnings: 3754000
Return on net tangible assets (%): 3.5601498411494146
Capex to operating income (%): 24.160683097224915
Buffett classification: The Great
Stock price: 13.12
P/E ratio: 13.219626199547477
Shares outstanding: 13805038
Book value: 173216000
P/B ratio: 1.0456430038795492
Market cap (USD): 181122098.56
Debt to equity: 0.11407722150378719
Current ratio: 4.283535085129416
Quick ratio: 2.037233868057606
Effective tax rate (%): 26.028765481422294
Interest coverage ratio: 29.445714285714285
COGS to revenue (%): 65.56540151701932
SG&A to revenue (%): 16.83514379776943
Free cash flow (dilution-adjusted): 14995000
Buyback yield (%): 0.5118094409075733
Retained earnings: 170203000
Inventory turnover: 0.6602213979028536
Receivables turnover: 1.4887401489798122
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6890922943650652
FCF margin (%): 21.747327812504533
Revenue growth (%): -8.425526263364102
Rule of 40 score: 13.321801549140432